scispace - formally typeset
J

Johannes Huebner

Researcher at Ludwig Maximilian University of Munich

Publications -  97
Citations -  4343

Johannes Huebner is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Enterococcus faecalis & Enterococcus faecium. The author has an hindex of 36, co-authored 91 publications receiving 3962 citations. Previous affiliations of Johannes Huebner include University of Freiburg & University Medical Center.

Papers
More filters
Journal ArticleDOI

Coagulase-Negative Staphylococci: Role as Pathogens

Johannes Huebner, +1 more
- 01 Jan 1999 - 
TL;DR: Coagulase-negative staphylococci are by far the most common cause of bacteremia related to indwelling devices and their important role as pathogens and their increasing incidence have been recognized and studied in recent years.
Journal ArticleDOI

Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides.

Francesca Fabretti, +6 more
- 01 Jul 2006 - 
TL;DR: The data suggest that the absence of d-alanine in LTA plays a role in environmental interactions, probably by modulating the net negative charge of the bacterial cell surface, and therefore it may be involved in the pathogenesis of this organism.
Journal ArticleDOI

Pathogenesis and immunity in enterococcal infections.

Irina Sava, +2 more
- 01 Jun 2010 - 
TL;DR: Several proteins and carbohydrate- or glycoconjugates that have been identified as putative virulence factors involved in the pathogenesis of enterococcal infections and may be used as targets for alternative therapies are summarized.
Journal ArticleDOI

Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor.

Markryan Dwyer, +8 more
- 01 Jan 2014 - 
TL;DR: It is suggested that targeting MIF by small molecular inhibitors might reduce the presence of extracellular DNA and serve as an adjunct to the use of antimicrobial drugs that could ultimately reduce bacterial fitness in the lungs during the later stages of CF disease.
Journal ArticleDOI

Enterococcal infections: host response, therapeutic, and prophylactic possibilities.

Stefanie Koch, +5 more
- 17 Feb 2004 - 
TL;DR: The development of an enterococcal vaccine based on capsular polysaccharides may improve the ability to prevent and treat these infections and the search for alternative treatment and preventive options is important.